The ability of EA to hinder invasiveness of VEGFR-2 expressing bladder cancer cells in response to VEGF-A was also confirmed using an in vitro three-dimensional spheroid-based assay in the collagen I matrix (Figure 3C,D). This evidence concerns the gene KDR and urinary bladder carcinoma.